Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Infectious Diseases
  4. Resources
  5. Guidelines

Guidelines

  • Antimicrobial Stewardship (23)
  • Avian Influenza (Bird Flu) (1)
  • COVID-19 (21)
  • Fever (4)
  • Fungal Infections (8)
  • H1N1 (Swine) Influenza (60)
  • HIV & AIDS (70)
  • Infections (61)
  • Lower Respiratory Tract Infections (131)
  • Measles (2)
  • MRSA (8)
  • Other (240)
  • Resources (638)
    • Charts (105)
    • Drug Allergy (20)
    • Drug Resistance (170)
    • Drugs (423)
    • Guidelines (99)
    • Letters (17)
    • Natural Medicines/Supplements (15)
    • Patient Education (57)
    • PL Voices (148)
    • Quality Measures (10)
  • STIs (109)
  • Skin/Soft Tissue Infections (100)
  • Travel Medicine (69)
  • Upper Respiratory Tract Infections (201)
  • Vaccines (321)
  • West Nile Virus (11)
91 - 99 of 99 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA): An Update October 2006
Guideline: Sexually Transmitted Diseases Treatment Guidelines (CDC, 2015) September 2006
Guideline: Recommended Antimicrobial Agents for Treatment and Postexposure Prophylaxis of Pertussis (2005) February 2006
Commentary: Prevention and Treatment of Pertussis Infection February 2006
Commentary: Updated Information Concerning Mosquito Repellents June 2005
Guideline: CDC Updated Information Regarding Mosquito Repellents June 2005
Guideline: US Public Health Service Guidelines for Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis (2001) March 2005
Commentary: Antiretroviral Postexposure Prophylaxis After Nonoccupational Exposure to HIV March 2005
Guideline: US Public Health Service Guidelines for Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis (2005) March 2005
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved